
A Clinical Trials Manual From The Duke Clinical Research Institute Lessons from a Horse Named Jim
by Liu, Margaret; Davis, Kate-
We Buy This Book Back!
-
eCampus.com Device Compatibility Matrix
Click the device icon to install or view instructions
Buy New
Buy Used
Rent Book
Rent Digital
How Marketplace Works:
- This item is offered by an independent seller and not shipped from our warehouse
- Item details like edition and cover design may differ from our description; see seller's comments before ordering.
- Sellers much confirm and ship within two business days; otherwise, the order will be cancelled and refunded.
- Marketplace purchases cannot be returned to eCampus.com. Contact the seller directly for inquiries; if no response within two days, contact customer service.
- Additional shipping costs apply to Marketplace purchases. Review shipping costs at checkout.
Summary
Author Biography
Kate Davis is Business Development Specialist for DCRI Communications Group, Durham, NC, US.
Table of Contents
Foreword | |
Preface | |
List of Abbreviations | |
Lessons from a Horse Named Jim and Other Events in History Affecting the Regulation of Clinical Research | |
The Process: Developing New Drugs, Biologics, and Devices | |
The Drug Development Process | |
Developing New Devices | |
Postmarketing Surveillance of Drugs, Biologics, and Devices | |
Good Clinical Practice and the Regulations | |
Good Clinical Practice | |
Responsibilities in the Code of Federal Regulations | |
Where to Obtain Information and Guidance for the Regulations and GCP | |
Informed Consent and the Regulations | |
What Is Informed Consent? | |
Ethical Codes Regarding Informed Consent | |
Regulatory Requirements for Informed Consent | |
The Informed Consent Process | |
Institutional Review Boards | |
What is an Institutional Review Board? | |
IRB Activities | |
Types of IRB Review | |
Communication between IRBs and Investigators | |
Communication between IRBs and Study Sponsors | |
IRB Records and Reports | |
Accreditation of IRBs | |
Registration | |
Adverse Events and Unanticipated Problems Involving Risks to Subjects or Others | |
Why Collect Adverse Event Data? | |
Adverse Events | |
Unanticipated Problems Involving Risks to Subjects or Others | |
Investigator Responsibilities | |
IRB Responsibilities | |
Sponsor Responsibilities | |
Monitoring, Audits, and Inspections | |
Monitoring Plan | |
On-Site Monitoring | |
In-House Monitoring | |
Audits and Inspections | |
The Principal Investigator, the Clinical Research Coordinator, and the Study Site | |
The Principal Investigator | |
Staffing to Support Clinical Trials | |
Space and Resource Needs | |
The Local Institutional Review Board | |
The Protocol | |
Common Components of a Protocol | |
Background and Rationale | |
Study Organization | |
Objectives/Endpoints | |
Study Design | |
Study Population | |
Study Treatment Plan | |
Safety Assessment, Management, and Reporting | |
Replacement of Withdrawn, Dropped Out, and Lost to Follow-up Subjects | |
Statistical Aspects | |
Subject Data and Record Retention | |
Monitoring | |
Study Feasibility: Reviewing a Specific Protocol | |
Reviewing a Specific Protocol | |
Should We Do this Study at Our Site? | |
Study Activities | |
Study Start-up Phase | |
Study Maintenance Phase | |
Study Completion and Close-Out Phase | |
Study Documents/Essential Documents | |
Documents at Study Start-Up | |
Documents While the Study is in Progress | |
Documents at Study Close-out | |
Maintaining Your Site Study File | |
Management of Study Drugs, Biologics, and Devices | |
Study Drugs and Biologics | |
Study Devices | |
Managing Clinical Trial Data | |
HIPAA, the Privacy Rule, and Clinical Trial Data | |
Guidelines and Regulations Regarding Clinical Trial Data | |
Study Site Responsibilities Regarding Clinical Trial Data | |
Source Document Verification of Clinical Trial Data | |
Release of Protected Medical Information | |
Confidentiality of Clinical Trial Data | |
Endpoint Adjudication | |
Global Health and International Trials | |
International Clinical Trials | |
Ethnic and Racial Differences | |
Ethical Issues and Cultural Sensitivities | |
Why International Trials Are Important | |
International Regulations | |
Concerns | |
Future Efforts | |
Appendices | |
Epilogue | |
Glossary | |
Index | |
Table of Contents provided by Publisher. All Rights Reserved. |
An electronic version of this book is available through VitalSource.
This book is viewable on PC, Mac, iPhone, iPad, iPod Touch, and most smartphones.
By purchasing, you will be able to view this book online, as well as download it, for the chosen number of days.
Digital License
You are licensing a digital product for a set duration. Durations are set forth in the product description, with "Lifetime" typically meaning five (5) years of online access and permanent download to a supported device. All licenses are non-transferable.
More details can be found here.
A downloadable version of this book is available through the eCampus Reader or compatible Adobe readers.
Applications are available on iOS, Android, PC, Mac, and Windows Mobile platforms.
Please view the compatibility matrix prior to purchase.